Samir Jegham

780 total citations
17 papers, 408 citations indexed

About

Samir Jegham is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Samir Jegham has authored 17 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 5 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Samir Jegham's work include Neurotransmitter Receptor Influence on Behavior (4 papers), Lanthanide and Transition Metal Complexes (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Samir Jegham is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (4 papers), Lanthanide and Transition Metal Complexes (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Samir Jegham collaborates with scholars based in France, Belgium and United States. Samir Jegham's co-authors include Pascal George, Bhupesh C. Das, F. Durant, Johan Wouters, Hichem Ben Jannet, Zine Mighri, F. Moureau, G. Evrard, Alistair W. Lochead and Olivier Bergis and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Tetrahedron Letters and European Journal of Medicinal Chemistry.

In The Last Decade

Samir Jegham

16 papers receiving 394 citations

Peers

Countries citing papers authored by Samir Jegham

Since Specialization

Citations

This map shows the geographic impact of Samir Jegham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Jegham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Jegham more than expected).

Fields of papers citing papers by Samir Jegham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir Jegham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Jegham. The network helps show where Samir Jegham may publish in the future.

Co-authorship network of co-authors of Samir Jegham

This figure shows the co-authorship network connecting the top 25 collaborators of Samir Jegham. A scholar is included among the top collaborators of Samir Jegham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir Jegham. Samir Jegham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Baclofen in managing acute alcohol withdrawal: preliminary findings from a randomised controlled trial 2018 ·European Neuropsychopharmacology ·Samir Jegham, Cleo L. Crunelle, Frieda Matthys	1
2	Pilot Scale Process Development of SL65.0102-10, anN-Diazabicyclo[2.2.2]-octylmethyl Benzamide 2016 ·Organic Process Research & Development ·Philippe Lienard, (unknown), (unknown), Samir Jegham, (unknown)	6
3	SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemias 2012 ·Leukemia & lymphoma ·Bernard Bourrié, Diana Brassard, (unknown), Asher Zilberstein, K T Yu, Mikhail Levit, (unknown), (unknown), Samir Jegham, Sandrine Hilairet, Monsif Bouaboula, Géraldine Pénarier, (unknown), (unknown), Guy Laurent, Cécile Demur, Pierre Casellas	8
4	SL25.1131 [3(S),3 a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3 a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile 2004 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Pascal Barnéoud, Christopher Carter, D. Caille, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Frédéric Puech, Samir Jegham, Pascal George, B. Scatton, O. Curet	11
5	Antibacterial activities of a few prepared derivatives of oleanolic acid and of other natural triterpenic compounds 2003 ·Comptes Rendus Chimie ·(unknown), Hichem Ben Jannet, (unknown), Samir Jegham, Zine Mighri	78
6	Synthesis and in vivo imaging properties of [11C]befloxatone: A novel highly potent positron emission tomography ligand for mono-amine oxidase-A 2003 ·Bioorganic & Medicinal Chemistry Letters ·Frédéric Dollé, Héric Valette, Yann Bramoullé, Ilonka Guenther, Chantal Fuseau, Christine Coulon, Carole Lartizien, Samir Jegham, Pascal George, O. Curet, (unknown), Michel Bottlaender	35
7	SL65.0155, A Novel 5-Hydroxytryptamine4 Receptor Partial Agonist with Potent Cognition-Enhancing Properties 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Paul Moser, Olivier Bergis, Samir Jegham, Alistair W. Lochead, (unknown), Jean-Paul Terranova, D. Caille, Isabelle Berque‐Bestel, Frank Lezoualc’h, Rodolphe Fischmeister, Aline Dumuis, Joël Bockaert, Pascal George, Philippe Soubrié, (unknown)	86
8	Molecular interaction between reversible MAO-A inhibitors and the enzyme. Application to aryloxazolidinone, a prototype series. 2000 ·PubMed ·Frédéric Ooms, Samir Jegham, (unknown), F. Durant, Johan Wouters	0
9	Mitsunobu N³-alkylation of 1,3,4-oxadiazol-2(3H)-ones 1999 ·Synthetic Communications ·Alistair W. Lochead, Francesco Galli, Samir Jegham, (unknown), (unknown)	9
10	A reversible monoamine oxidase a inhibitor, befloxatone: structural approach of its mechanism of action 1999 ·Bioorganic & Medicinal Chemistry ·Johan Wouters, F. Moureau, G. Evrard, (unknown), Samir Jegham, Pascal George, F. Durant	72
11	Molecular lipophilicity potential by clip, a reliable tool for the description of the 3D distribution of lipophilicity: Application to 3-phenyloxazolidin-2-one, a prototype series of reversible MAOA inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·Frédéric Ooms, Johan Wouters, Sonia Collin, F. Durant, Samir Jegham, Pascal George	8
12	Monoamine oxidase A and B inhibitors 1998 ·Expert Opinion on Therapeutic Patents ·Samir Jegham, Pascal George	13
13	Use of chiral glycerol 2,3-carbonate in the synthesis of 3-aryl-2-oxazolidinones 1998 ·Tetrahedron Letters ·Samir Jegham, (unknown), (unknown), (unknown), Frédéric Puech, (unknown), Pascal George	10
14	Reversible inhibition of type B monoamine oxidase. Theoretical study of model diazo heterocylic compound 1997 ·European Journal of Medicinal Chemistry ·Johan Wouters, Frédéric Ooms, Samir Jegham, (unknown), (unknown), F. Durant	25
15	A new route to optically pure cis- and trans-2,5-disubstituted pyrrolidines 1989 ·Tetrahedron Letters ·Samir Jegham, Bhupesh C. Das	17
16	An enantiospecific synthesis of (+)- and (−)-20-epi-ibophyllidine via an intramolecular diels-alder type cyclization 1989 ·Tetrahedron Letters ·Samir Jegham, Jean‐Louis Fourrey, Bhupesh C. Das	11
17	A new synthesis of (−)-anisomycin or (+)-anisomycin starting from D-tyrosine or L-tyrosine 1988 ·Tetrahedron Letters ·Samir Jegham, Bhupesh C. Das	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact